Soluble intercellular adhesion molecule-1 is related to endothelial vasodilatory function in healthy individuals

Atherosclerosis

Volumn 165, Issue 2, 2002, Pages 271-276

  Holmlund, A ^a   Hulthe, J ^b   Millgard J ^a   Sarabi, M ^a   Kahan, T ^c   Lind, L ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adhesion molecules; C reactive protein; Endothelium; Inflammation; Vasodilatation

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; METHACHOLINE; NITROPRUSSIDE SODIUM; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; CONTROLLED STUDY; FEMALE; FOREARM; HUMAN; INFLAMMATION; INTIMA; MALE; MORPHOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; SMOKING; TUNICA MEDIA; ULTRASOUND; VASCULAR ENDOTHELIUM; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY; BLOOD; EVALUATION; HISTOLOGY; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERY, COMMON; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; TUNICA INTIMA; VASCULAR CELL ADHESION MOLECULE-1; VASODILATION;

EID: 0036890096     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00234-4     Document Type: Article

References (32)

1. Danesh J., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses [see comments]. Br. Med. J. 321:(7255):2000;199-204.
2. Lagrand W.K., et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation. 100:(1):1999;96-102.
3. Danesh J., et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. J. Am. Med. Assoc. 279:(18):1998;1477-1482.
4. Poston R.N., et al. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am. J. Pathol. 140:(3):1992;665-673.
5. Hwang S.J., et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 96:(12):1997;4219-4225.
6. Ridker P.M., et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men [see comments]. Lancet. 351:(9096):1998;88-92.
7. Taddei S., et al. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 21:(6 Pt 2):1993;929-933.
8. Creager M.A., et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J. Clin. Invest. 86:(1):1990;228-234.
9. Johnstone M.T., et al. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 88:(6):1993;2510-2516.
10. Zeiher A.M., Schachinger V., Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation. 92:(5):1995;1094-1100.
11. Burke G.L., et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 26:(3):1995;386-391.
12. O'Leary D.H., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 340:(1):1999;14-22.
13. Bruning T.A., et al. Comparison of cholinergic vasodilator responses to acetylcholine and methacholine in the human forearm. Blood Press. 5:(6):1996;333-341.
14. Lind L., et al. Evaluation of endothelium-dependent vasodilation in the human peripheral circulation. Clin. Physiol. 20:(6):2000;440-448.
15. Lind L., Sarabi M., Millgard J. Methodological aspects of the evaluation of endothelium-dependent vasodilatation in the human forearm. Clin. Physiol. 18:(2):1998;81-87.
16. Wiklund O., et al. Cell adhesion molecules and secretory type II phospholipase A2 in relation to carotid atherosclerosis in patients with hypercholesterolaemia. J. Intern. Med. 249:(5):2001;441-449.
17. Schachinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 101:(16):2000;1899-1906.
18. Suwaidi J.A., et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 101:(9):2000;948-954.
19. John S., et al. Plasma soluble adhesion molecules and endothelium-dependent vasodilation in early human atherosclerosis. Clin. Sci. (Colch). 98:(5):2000;521-529.
20. Hak A.E., et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler. Thromb. Vasc. Biol. 19:(8):1999;1986-1991.
21. Hulthe J., Wikstrand J., Fagerberg B. Relationship between C-reactive protein and intima-media thickness in the carotid and femoral arteries and to antibodies against oxidized low-density lipoprotein in healthy men: the Atherosclerosis and Insulin Resistance (AIR) study. Clin. Sci. (Colch). 100:(4):2001;371-378.
22. Tracy R.P., et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler. Thromb. Vasc. Biol. 17:(10):1997;2167-2176.
23. Hashimoto H., et al. C-reactive protein is an independent predictor of the rate of increase in early atherosclerosis. Circulation. 104:2001;63-67.
24. Malmqvist K., et al. Soluble E-selectin and VCAM are incerased in concentric left ventricular hypertrophy and realtion to septal wall thickness. J. Hypertens. 18:2000;130. Supplement.
25. Held C., et al. Cellular adhesion molecules and leucocyte counts are related to the degree of atherosclerosis in the carotid and femoral arteries assessed by ultrasonography. Circulation. 1998;242. Supplement.
26. De Caterina R., et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17:(11):1997;2646-2654.
27. Rohde L.E., et al. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 18:(11):1998;1765-1770.
28. Silverman M.D., et al. Cell adhesion molecule expression in cultured human endothelial cells. Invest. Ophtalmol. Vis. Sci. 42:2001;2861-2866.
29. Berendji-Grun D., et al. Nitric oxide inhibits endothelial IL-1-induced ICAM-1 gene expression at the transcriptional level decreasing SP1 and AP-1 activity. Mol. Med. 7:2001;748-754.
30. Lindemann S., et al. NO reduces PMN adhesion to human vascular endothelial cells due to downregulation of ICAM-1 mRNA and surface expression. Thromb. Res. 97:2000;113-123.
31. Koh K.K., et al. Vascular effects of estrogen and vitamin E theapies in postmenopausal women. Circulation. 100:1999;1851-1857.
32. Aljada A., et al. Insulin inhibits the expression of intracellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J. Clin. Endocrinol. Metab. 85:2000;2572-2575.